Lister strain of vaccinia virus armed with endostatin-angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer
about
CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic VirusesMolecular imaging of oncolytic viral therapyOncolytic viral therapy for pancreatic cancer: current research and future directionsOncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.Gene therapy in pancreatic cancer.The combination of immunosuppression and carrier cells significantly enhances the efficacy of oncolytic poxvirus in the pre-immunized host.Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin.Efficiently editing the vaccinia virus genome by using the CRISPR-Cas9 system.Oncolytic virotherapy for pancreatic cancer.Bevacizumab with angiostatin-armed oHSV increases antiangiogenesis and decreases bevacizumab-induced invasion in U87 glioma.A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9.Features of the Antitumor Effect of Vaccinia Virus Lister StrainTargeting tumor vasculature through oncolytic virotherapy: recent advances.Novel therapies for pancreatic cancer: setbacks and progressVaccinia virus, a promising new therapeutic agent for pancreatic cancer.Oncolytic vaccinia virus for the treatment of cancer.Update on oncolytic viral therapy - targeting angiogenesisPancreatic cancer gene therapy: from molecular targets to delivery systems.T-cell engager-armed oncolytic vaccinia virus significantly enhances antitumor therapy.Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery.Lister strain vaccinia virus with thymidine kinase gene deletion is a tractable platform for development of a new generation of oncolytic virus.Vascular endothelial growth factor A promotes vaccinia virus entry into host cells via activation of the Akt pathway.Oncolytic viral therapy for pancreatic cancer.Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes.Viral gene therapy for breast cancer: progress and challenges.Differential biodistribution of oncolytic poxvirus administered systemically in an autochthonous model of hepatocellular carcinoma.A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors.4th European Seminars in Virology on Oncogenic and Oncolytic Viruses, in Bertinoro (Bologna), Italy.Development of the hybrid Sleeping Beauty: baculovirus vector for sustained gene expression and cancer therapy.Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose.
P2860
Q26766798-9998D526-1EDA-422D-8981-56C06EFDC39BQ26999406-C01F6551-C040-49D7-BCB1-A4C72B9BE786Q27011439-67496D34-6E04-44D5-BAA1-D7510D41C5CFQ33906116-DC2A0B54-6565-477A-AFED-9EFBA0954F25Q34302954-1060BA0B-56C8-4FDD-A288-445C283C4459Q34316241-224EEA14-1694-422F-B68E-681715F76FFAQ35124738-C6F0A334-3EF8-4E23-B3E2-33A1053EB572Q35488657-AD6E4917-2EDB-4CF9-A90D-0C02ABAEEE2CQ35590996-871EE500-0B18-4D19-BC4E-42D4B010530CQ35665220-033647B7-842D-410B-848F-FCC5ECB3A8CBQ36064702-9FAC8DC7-0D5D-41FC-8C61-FA711E67B85AQ36507293-C8CE7EF7-A7B1-4251-A925-8BDDE8166637Q37031932-1A2FFAEE-835F-4023-8551-08AF800504BCQ37107622-C63216BD-C9F5-40AE-8379-EFCB1D1BC59DQ37158473-222A548C-8447-4A74-93FA-03894B1F9E0FQ37845399-8238A377-934B-470B-B01F-127673351592Q38128561-5E79B762-C4B5-42F4-97E6-807865EA3CF2Q38161331-65144544-7AAF-46BC-8204-34672D9C400EQ38648630-A4FE254C-55A7-4A15-BBE9-8371E6EE55BAQ38673968-03969B2D-5B68-4578-B2B0-02299421EC86Q38886874-0D1F5D26-CCBF-41CB-BEC7-85A4C45125D8Q39220397-48E26E8E-38F0-480F-8EFD-78C81158DBC8Q39240683-AA61E4D4-1D4C-43E0-8C53-A342428127B2Q39359422-C38D9898-E0D0-4BD2-91B2-82D8442AAFB6Q39366114-3E3062EE-EE7F-4FA1-B119-8B98BCCE115DQ39452616-769C4E0B-79D9-4EC2-8D9C-2DF068D323CAQ40452852-D2A9A5B2-E778-4B91-9E6E-7E9259890781Q40470227-6CE2DB57-FD2E-4A60-A01B-B7BE905E5F89Q44162630-3EB13EF5-AB40-4E03-8ED8-7C694414D1F3Q52716434-CD79FB95-47CC-44D0-AA27-4D245402DF17
P2860
Lister strain of vaccinia virus armed with endostatin-angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lister strain of vaccinia viru ...... nt for human pancreatic cancer
@en
Lister strain of vaccinia viru ...... t for human pancreatic cancer.
@nl
type
label
Lister strain of vaccinia viru ...... nt for human pancreatic cancer
@en
Lister strain of vaccinia viru ...... t for human pancreatic cancer.
@nl
prefLabel
Lister strain of vaccinia viru ...... nt for human pancreatic cancer
@en
Lister strain of vaccinia viru ...... t for human pancreatic cancer.
@nl
P2093
P2860
P356
P1433
P1476
Lister strain of vaccinia viru ...... nt for human pancreatic cancer
@en
P2093
J R Tysome
N R Lemoine
P2860
P2888
P304
P356
10.1038/GT.2009.74
P577
2009-07-09T00:00:00Z